Biopharma EHS

Categories

general

Archives

2016
January

2014
November
October

2013
July
June

2012
July
January

2011
December
May
April
March
February
January

2010
December

March 2017
S M T W T F S
     
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Syndication

In this podcast, Dean M. Calhoun, CIH and Joe Nieusma, Ph.D. of Affygility Solutions discuss Category 4 and Category 5 Potent Compounds - Understanding the Risks.

Items covered include:

  • Review of the last podcast
  • What factors go into determining an active pharmaceutical ingredients as a Category 4 or Category 5 potent compound
  • We provide examples of Category 4 and Category 5 potent compounds
  • Review upcoming events and happenings related to environmental, health and safety in the biotechnology, pharmaceutical, and medical device industry.

If you have any questions please contact Affygility Solutions at 303-884-3028 or visit the Affygility Solutions website.

Direct download: Biopharma_EHS_Podcast_Episode_No._16.mp3
Category:general -- posted at: 11:51am MDT